VIDO funded $24M to help develop 'holy grail' coronavirus vaccine
The Vaccine and Infectious Disease Organization (VIDO) at the University of Saskatchewan has been awarded a $24 million grant to help develop a vaccine to protect against wide-ranging strains of coronaviruses. VIDO's funding flows from Norwegian-based …